Salvage treatment of relapsed or refractory germ-cell tumours - authors' reply

Lancet Oncol. 2013 Nov;14(12):e486-7. doi: 10.1016/S1470-2045(13)70474-1.

Authors

Rüdiger Wessalowski¹, Dominik T Schneider, Ulrich Göbel, Gabriele Calaminus; MAKEI study group

Affiliation

¹ Clinic of Paediatric Oncology, Haematology and Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Moorenstrasse 5, Düsseldorf 40225, Germany. Electronic address: wessalowski@med.uni-duesseldorf.de.

PMID: 24176561
DOI: 10.1016/S1470-2045(13)70474-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Drug Resistance, Neoplasm*
Female
Humans
Hyperthermia, Induced*
Male
Neoplasm Recurrence, Local / therapy*
Neoplasms, Germ Cell and Embryonal / therapy*
Salvage Therapy*